Chemical Weight Loss Retatrutide / Ly-3437943 CAS 2381089-83-2 Vial 10mg 20mg Reta Peptide

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: Frazer-Retatrutide
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: White Freeze-Dried Powder
• Purity: >99%
• Appearance: White Freeze-Dried Powder
• Shelf Life: 2 Years
• Test Method: HPLC
• MOQ: 1box
• Storage: Store Cool Dry Place
• Resource: Natural
• Quality Requirement: Strictly Quality Control
• Market: Worldwide
• Service: Welcome to Visit Us
• Delivery Time: 7-10days
• Transport Package: Foil Bag
• Specification: 99%
• Trademark: Xi′an Frazer Biotech Co., Ltd.
• Origin: China
• Production Capacity: 200box/Month

Product Description

Chemical Weight Loss Retatrutide / Ly-3437943 CAS 2381089-83-2 Vial 10mg 20mg Reta Peptide

 

Description:
Retatrutide operates through a unique mechanism as a triple agonist, targeting the GIP, GLP-1, and GCG receptors, with a strong emphasis on GIP receptor activation.

This receptor interaction leads to a comprehensive approach to metabolic regulation, significantly impacting both glycemic control and weight loss. Below is an overview of the underlying mechanisms:

• Retatrutide's primary mechanism involves potent activation of the GIP receptor, which plays a vital role in appetite regulation by directly affecting the brain's satiety centers. This reduces hunger, cravings, and overall food intake.
• Through GLP-1 receptor activation, retatrutide supports glycemic regulation and enhances satiety. GLP-1 also slows down gastrointestinal motility and delays gastric emptying, leading to increased feelings of fullness after meals.
• Activation of the GCG receptor by retatrutide is believed to increase energy expenditure and promote fat oxidation, largely through metabolic actions in the liver. GCG receptor stimulation encourages fat breakdown and elevates metabolic rates. Additionally, it induces "beiging" of white fat, converting it into beige fat with thermogenic properties similar to brown fat, thereby boosting calorie burning and enhancing metabolism.  

These combined mechanisms make retatrutide a promising option for treating obesity and type 2 diabetes by not only curbing calorie intake but also increasing energy expenditure, offering a dual strategy for effective weight management.

 

Application:

Retatrutide acts on the central nervous system, especially the appetite regulation center of the hypothalamus. It can reduce appetite and make people feel full, thus reducing food intake. In addition, it may also affect the peristalsis and emptying speed of the gastrointestinal tract, further controlling the intake of food and the digestion and absorption process. In terms of fat metabolism, it may promote the conversion of white adipose tissue to brown adipose tissue, which is more active in energy metabolism and able to consume more energy, contributing to weight loss